Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'

Abstract

Sir, In their paper, Lu et al (2015) correctly stressed the complex relationships between the type 2 diabetes and pancreatic cancer risk. However, their study failed to explicitly define three distinct relationships. In the absence of this framework, their conclusions that ‘Newonset type 2 diabetes and y. diabetes with rising HbA1c (levels) seem to be… (More)
DOI: 10.1038/bjc.2016.99

Topics

Cite this paper

@inproceedings{Badrick2016CommentO, title={Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'}, author={Ellena L. Badrick and Matthew Sperrin and Andrew G Renehan}, booktitle={British Journal of Cancer}, year={2016} }